(19)
(11) EP 1 276 755 A1

(12)

(43) Date of publication:
22.01.2003 Bulletin 2003/04

(21) Application number: 01930760.2

(22) Date of filing: 26.04.2001
(51) International Patent Classification (IPC)7C07H 21/04, C12P 21/06, C12N 9/00, C12N 1/20, C12N 15/00
(86) International application number:
PCT/US0113/360
(87) International publication number:
WO 0108/1363 (01.11.2001 Gazette 2001/44)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 27.04.2000 US 199963 P
11.05.2000 US 203336 P
25.05.2000 US 207087 P
26.05.2000 US 207546 P

(71) Applicants:
  • SmithKline Beecham Corporation
    Philadelphia, PA 19103 (US)
  • Smithkline Beecham PLC
    Brentford,Middlesex TW8 9EP (GB)

(72) Inventors:
  • AGARWAL, Pankaj
    King of Prussia, PA 19406 (US)
  • MURDOCK, Paul, R.
    Harlow,Essex CM19 5AW (GB)
  • RIZVI, Safia, K.
    Philadelphia, PA 19143 (US)
  • SMITH, Randall, F.
    Lafayette Hill, PA 19444 (US)
  • XIANG, Zhaoying
    Fort Lee, NJ 07024 (US)
  • KABNICK, Karen, S.
    Lafayette Hill, PA 19444 (US)
  • LAI, Ying-Ta
    Upper Darby, PA 19082 (US)
  • XIE, Qing
    Horsham, PA 19044 (US)

(74) Representative: Giddings, Peter John, Dr. et al
GlaxoSmithKlineCorporate Intellectual Property (CN9.25.1)980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)

   


(54) NOVEL COMPOUNDS